were found in skin and bladder cancer, cadmium in breast and prostate cancers, and copper and iron in respiratory and urinary tract cancers. [4] Undoubtedly, by early diagnosis of precancerous lesions based on the values of micronutrients, the occurrence of cancers may be decreased. [5, 6] Moreover, shortage of zinc has been reported in a few malignant lesions, which may interfere with the healing of lesions, functional defect of the immune system, and causes acceleration of tumor growth among animals. [7] [8] [9] Due to the crucial role of copper, ferritin, and selenium in the structures of various body enzymes, it seems that changes in their serum levels play a role in the pathogenesis of oral cancer.
Iron (stored in the form of ferritin) is one of the main micronutrients whose insufficiency that is prevalent all over the world may cause oral cancer by inducing oxidative stress. Lack of balance between oxidative events and ability to remove them by enzymatic and non-enzymatic antioxidants results in oxidative stress. This reaction causes serious damage to cells and DNA because of producing excessive free radicals or decreasing the antioxidant defense or both. [10, 11] Oxidative damages are mostly followed by decline in the function of antioxidant enzymes. Decrease or increase of rare elements such as zinc, copper, and ferritin may influence the activities of antioxidant enzymes as well. [12, 13] Meanwhile, some remarkable statistical changes in the distribution of nutritional elements such as iron and copper in patients with various neoplasms have been reported. [14] Consequently, serum level of micronutrients has been propounded as an effective biochemical marker in the diagnosis of oral cancer whose significance has recently been put forth by researchers and has opened a new way for diagnosis and treatment of many diseases, especially blood dyscrasias, accordingly. In recent years, micronutrients have been examined to a great extent in order to evaluate their probable role in the etiology of various kinds of cancers. Measurement of serum levels of micronutrients is not only useful for diagnosis but also an appropriate guide for prognosis of the disease. [15] This research has been conducted to measure the quantities of copper, ferritin, and zinc in blood of patients with oral cancer.
METHODS
This cross-sectional study was conducted on 60 patients with oral and maxillofacial cancer at the Cancer Institute of Tehran University of Medical Sciences and 66 otherwise healthy persons. Subjects of the control group neither had cancer nor suffered from systemic diseases. Meanwhile, they were matched with cancer patients in terms of age and gender. The control group and cancer group patients had not used food supplements either.
At first, respective examinations were conducted on the inpatients hospitalized at the Cancer Institute after the required authorizations were obtained. Then, a data form including demographics, and characteristics of lesions, as well as informed written consent were completed for them. At the hospital, 5 ml of blood sample of the patients was collected by registered nurses and then transferred to acid-wash tubes. Finally, the samples were transferred to the laboratory of the hospital. Then, the blood samples were centrifuged, the serum part was separated and kept in a refrigerator at − 70°C. Finally, all samples were analyzed at once for minimizing error. In order to measure the quantity of ferritin in serum, immunoenzymatic kits of Padtan-Elm Company (Tehran, Iran) were used. Quantities of zinc and copper were measured using the kits of Grainer Company (Frickenhausen, Germany).
Measurement of zinc was done by means of colorimetric test with 5-Brom-PAPS (2-(5-Bromo-2-pyridiylazo)-5-[N-n-propyl-N-(3-sulfopropyl) amino] phenol) and that of copper was conducted using colorimetric test with dibrom-PAESA (4-(3,5-Dibromo-2-pyridylazo)-N-ethyl-N-sulfopropylaniline) method by an autoanalyzer (Mindray BS-380, Shenzhen, China). Moreover, ferritin was measured by means of an ELISA (enzyme-linked immunosorbent assay) Reader (Alpha Diagnostic Intl. Inc.,| San Antonio, Texas, USA).
Mean and standard deviation of the quantitative values of micronutrients in patients and healthy people were determined, and the frequency (percentage) of different kinds of oral cancerous lesions with location of tumors in patients was estimated accordingly. Quantities of ferritin, copper, and zinc in the two groups of patients and control were compared using Mann-Whitney U non-parametric test because the distribution of these variables was not normal. The same variables were distributed normally when compared between different sexes in case and control groups. Therefore, Student's t-test was used for statistical analysis. Distribution of gender in cancerous and non-cancerous patients was analyzed using Chi-square test. SPSS software version 18 was used for statistical analysis.
RESULTS
This research was conducted on 60 patients with oral cancer and 66 healthy persons. Average age of patients with oral cancer was 61.43 ± 15.73 years and that of the control group subjects was 59.8 ± 13.65 years. Student's t-test showed that there was no significant difference between the two groups with regard to age (p = 0.533). Of the 60 patients with oral cancer, 35 (26.9% of total) were men and 25 (19.2% of total) were women. Among the individuals of the control group (n = 66), 40 persons (30.8% of total) were men and 26 (20% of total) were women. Chi-square test showed that there was no significant difference between the two groups in terms of sex (p = 0.891).
The most frequent kind of cancer among our patients was squamous cell carcinoma (SCC). No significant difference was found between men and women in terms of tumor type (p = 0.452).
Mean of ferritin level in the cancer group (267.41 ± 249.45 mg/dl) was significantly higher than in the control group (106.13 ± 72.96 mg/dl) (p < 0.001) [ Table 1 ]. Meanwhile, the values of ferritin in men and women with cancer were higher than the values in their healthy counterparts [ Table 2 ]. Furthermore, the average of ferritin in cancerous men was significantly higher than in cancerous women (p = 0.020).
The average of copper in the serum of patients with oral cancer (209.85 ± 160.28 mg/dl) was significantly higher than in the control group (114.20 ± 38.69 mg/dl) (p < 0.001).
Although not significant, the serum level of copper in men and women suffering from cancer was higher than the level in men and women of the control group [ Table 2 ].
The average of serum zinc level in patients with oral cancer (113.51 ± 52.30 mg/dl) was significantly higher than in the control group (64.57 ± 31.54 mg/dl) (p < 0.001) [ Table 1 ]. Moreover, the serum level of zinc in cancerous men was higher than that of women, but without a significant difference [ Table 2 ].
Values of serum ferritin, zinc, and copper based on cancer location have been given in Table 3 .
Patients having cancer in their tongue had the highest value of serum ferritin, and those with cancer in the floor of the mouth showed the least value of serum ferritin. The highest values of copper and zinc in cancerous patients were observed in lower lip and retromolar trigone, respectively, whereas the least values were seen in alveolar ridge and buccal mucosa.
DISCUSSION
Results showed that the serum copper level in patients with oral cancers compared to the individuals of healthy group showed a significant increase. The above findings are inconsistent with the results obtained in bladder, [16] breast, [17] colorectal, [18] and gastrointestinal cancers. [18, 19] In another study, the serum levels of copper in cancerous and precancerous lesions were found to be significantly increased. [15] Meanwhile, it has been found that Cu chelator compounds may act as tumor restraining factors. [20] According to a research conducted in this regard, Tetrathiomolybdate (TTM) has been found as a copper chelator in different kinds of cancers, which is capable of stopping tumor growth and preventing recurrence. [21] Copper ion plays a prominent role in producing free oxygen metabolites due to oxidation and regeneration activity. [22] Free radicals are able to connect to natural parts of cell, leading to peroxidation of lipids, oxidation of proteins, and destruction of nucleic acids. [17] In this way, free radicals have a role in development and prognosis of carcinogenesis and causing various cancers. Consequently, increase of serum copper level due to increase of oxidation processes may promote suitable grounds in individuals to develop oral cancer. There is a relationship between increase of serum copper level in patients suffering from oral cancers and that of activity of ceruloplasmin (globulin containing copper) with major oxidase activity [23] in the serum of patients suffering from cancer.
Zinc is one of the rare elements whose serum level changes are effective in oxidation and regeneration processes as well as development of carcinogenesis. [17] In this study, the value of serum zinc in individuals with oral cancer was apparently higher than in the control group. Changes have been observed in the serum levels of zinc in different tumor types. For example, the serum level of zinc in cancers of bladder, [16] prostate [24] stomach, [25] and gall bladder has been found to be decreased, [26] and in thyroid cancer, it has been found to be increased. [27] Zinc is one of the antioxidants in food on which the activities of enzymes of the antioxidant system of the body, such as superoxide dismutase, depend. [28] Moreover, zinc may directly prevent DNA damage and eventually gene mutation, and in this way, the element decreases the risk of cancer accordingly. [29] Concerning the fact that oral cancerous and precancerous lesions contain inflammatory processes, it seems that long-term inflammation, associated with the above-mentioned lesions, may irritate oxidative stress. Not only does zinc participate in the transcription process as a cofactor, but also it has a role playing an active part in the enzymatic antioxidant system, including carbonic anhydrase, superoxide dismutase, and leucine aminopeptidase. All the above factors take part in homeostasis of body against the tumor progression. [15, 30] Contrary to the results of the present study, Ray et al., indicated that serum value of zinc in patients with leukoplakia had clearly decreased. [31] This finding may be related to the different nature of lesions. Moreover, values of zinc in patients with cancer were close to the normal range, while the individuals of control group showed lower values, which probably reveals nutritional deficiencies in Iranian population as shown in several studies. [32, 33] Unlike our results, Prasad et al., found zinc deficiency and dysfunction of cell-mediated immunity in a number of patients with head and neck cancers. [34] Doerr et al., also reported that zinc inadequacy in patients with head and neck cancers has been associated with a few medical complications. [35] Increased level of zinc in patients suffering from oral cancer may be related to their dietary habits.
Major mechanisms through which zinc may affect oral cancer are still the topic of discussion. Role of zinc in the synthesis of nucleic acid, its effects in producing metallothioneins, grabbing free radicals, and its importance in the activity of cytotoxic T cells all are significant, and inadequacy of zinc may lead to occurrence or aggravation of malignant oral lesions. Meanwhile, animal studies revealed that zinc may aggravate tumor prognosis. [9] Moreover, primary studies on human beings indicate the role of zinc and other micronutrients in inducing treatment effects in patients with precancerous and cancerous lesions, [1] but more studies are required in this regard to elucidate the exact role of zinc in malignant lesions. In this study, we measured the serum level of ferritin instead of serum iron to minimize the effect of daily diet on our results.
Results of this study showed that the value of serum ferritin in patients with oral cancer was apparently higher than that of healthy individuals. In cancers of liver, stomach, and colon, the serum level of ferritin is noticeably found to be increased compared to that of normal persons. [36] However, the serum level of ferritin in patients with bladder cancer showed a meaningful decrease. [16] High values of serum ferritin may occur in reaction to infection, inflammation, and chronic diseases. [37] Ferritin levels may be increased in spite of ferritin deficiency or inadequacy. [38] Increased level of ferritin has been reported in patients with oral disease, [39] breast cancer, [40] Hodgkin's disease, and surgery in some studies. [41, 42] Biochemical functions of ferritin justify the essential role of iron in carcinogenesis. [41] Furthermore, review of literature showed that there are different concepts about the role of iron in carcinogenesis. Results of previous meta-analyses have not confirmed definite relationship between iron changes and cancer risk. However, in some studies, such relations have been proved. [42, 43] Ferritin is a part of the enzyme system which catalyzes electron transfer and respiration reactions, and has a pivotal role in cellular viability. [44] According to the results of Hossain et al. study, serum ferritin in patients with oral squamous cell carcinoma (OSCC), compared to healthy individuals, was apparently decreased. [45] Increase in serum ferritin may create free radicals and produce carcinogenesis effects. [46] Limited studies have been conducted on the relationship between ferritin and the risk of oral cancer. According to three studies, it has been found that upon decrease of ferritin, certain changes may take place leading to development of oral cancer. [47] [48] [49] On the other hand, no relationship was established between precancerous oral lesions and decrease of ferritin among Indian women. [50] Khanna reported significantly decreased level of ferritin among patients with precancerous and cancerous lesions by means of calorimetric method, which is inconsistent with our study result. [51] On the contrary, Richie et al., found a relationship between increased values of ferritin and total iron binding capacity with increased risk of oral cancer. [52] Mahdavi et al., studied the levels of serum copper, zinc, iron, and ferritin in hyperlipidemic and healthy individuals, in which the levels of serum lipids and ferritin were measured using enzymatic method, the levels of serum copper and zinc were measured using atomic absorption spectrophotometric method, and the values of ferritin were measured using ELISA method. The above methods are inconsistent with the methods used in our research to some extent. [53] The results of this study must be interpreted considering its certain limitations. First of all, levels of micronutrients in serum are affected by daily dietary patterns. Thus, in order to prove a definite role of the micronutrients for early diagnosis and improvement of prognosis, cohort complementary researches should be conducted.
Meanwhile, patients' biomarkers were measured after diagnosis of cancer and it was possible that their changes occurred due to alterations in recent dietary patterns.
Moreover, it is likely that development of oral cancer would change the balance of iron metabolism and affect serum ferritin accordingly. [52] 
Conclusions
Serum levels of ferritin, copper, and zinc in patients with oral cancerous lesions are significantly higher than those of healthy people.
